M&A Deal Summary

Boston Scientific Acquires Relievant Medsystems

On September 18, 2023, Boston Scientific acquired medical products company Relievant Medsystems for 850M USD

Acquisition Highlights
  • This is Boston Scientific’s 47th transaction in the Medical Products sector.
  • This is Boston Scientific’s 8th largest (disclosed) transaction.
  • This is Boston Scientific’s 47th transaction in the United States.
  • This is Boston Scientific’s 6th transaction in Minnesota.

M&A Deal Summary
Date 2023-09-18
Target Relievant Medsystems
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition
Deal Value 850M USD

Target

Relievant Medsystems

Edina, Minnesota, United States
Relievant Medsystems is a private, clinical-stage medical device company that is developing a novel treatment for chronic low back pain. The company's Intercept product, currently under development, is a minimally invasive system that allows a spine surgeon to target low back pain by ablating a nerve target within the vertebral body. Relievant Medsystems was formed in 2004 and is based in Edina, Minnesota.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States
Category Company
Founded 1979
Sector Medical Products
Employees48,000
Revenue 14.2B USD (2023)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 62 of 66
Sector (Medical Products) 47 of 50
Type (Add-on Acquisition) 48 of 51
State (Minnesota) 6 of 6
Country (United States) 47 of 51
Year (2023) 1 of 1
Size (of disclosed) 8 of 34
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-11 Acotec

Beijing, China

Acotec is a medical technology company that offers solutions designed for a variety of interventional procedures in innovative medical solutions, including drug-coated balloons (DCBs), which are used in the treatment of vascular and other diseases. In 2016, the company launched the first peripheral DCB in China after receiving approval from the National Medical Products Administration. The Acotec portfolio also includes radiofrequency ablation technologies and thrombus aspiration catheters, as well as more than 20 other products in various stages of development across a range of specialties. Acotec was incorporated in 2020 and is headquartered in Beijing, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-08 Axonics

Irvine, California, United States

Axonics is focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction. The Axonics product portfolio includes the Axonics R20TM and the Axonics F15TM Systems used to deliver sacral neuromodulation (SNM) therapy. SNM therapy is a minimally invasive procedure used in the treatment of OAB and fecal incontinence. It works by delivering mild electrical pulses to the sacral nerve to restore communication between the brain and the bladder. Axonics was founded in 2013 and is headquartered in Irvine, California.

Buy $3.7B
Mergr

Product

Company

Legal